According to the College of American Pathologists (CAP) 2013 data, approximately 80 percent of the world’s pathologists are based in the United States. This concentration causes an increased need to access, share, and diagnose images remotely.
Industry analysts predict most laboratories will switch to a digitized pathology workflow within 7 years. However, there remains a number of challenges within digital pathology that extend beyond the mere digitization of pathology images, including interconnectivity between geographic locations and devices, and providing efficiency in collaborative work.
Frost & Sullivan sees telepathology as the future of pathology and recently awarded Corista the New Product Innovation Leadership Award in Image-Centric Workflow Platforms for Digital Pathology. DP3 is acknowledged as an unrivaled solution for the future of pathology and tissue diagnosis.
For this award, Frost & Sullivan evaluated Corista for visionary innovation and excellence that reflected in multiple areas:
- Addressing key unmet challenges
- Matching market needs
- Providing a solution to meet megatrends
- Value and quality of product/service
- Pioneering best practices
To learn more about Frost & Sullivan’s forecasted trends in the digital pathology market and how Corista’s DP3 platform addresses them, download the full report by clicking here.